Novavax vaccine is highly protective against COVID-19 in Phase 3 results
June 14, 2021
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Elizabeth Allen, 210-358-2344, elizabeth.allen@uhs-sa.com SAN ANTONIO (June 14, 2021) — Researchers at UT Health San Antonio are buoyed by today’s news that the Novavax vaccine is strongly effective against the COVID-19 virus. Biotechnology company Novavax released Phase 3 clinical trial results from 119 sites in the U.S. and Mexico this […]
